RESISTENSI ANTIMIKROBA DI
RUMAH SAKIT
HARI PARATON. dr. SpOGK
WHO 2013
10.000.000/tahun
2050
USD. 100 TRILLIUN
(Jim O Neill 2015)
KOMITE PENGENDALIAN RESISTENSI ANTIMIKROBA
KEMENTERIAN KESEHATAN
BAGAIMANA INDONESIA
The prevalence of ESBL producing E.coli and RSUD.Dr. Soetomo 204 sample kasus
Klebsiella pneumoniae among hospitals in Jan-Juli 2010
Indonesia six hospitals 2013
N= 554
60 56,39% 56,8% 100.00%
51,69% 52,23% 90.00%
50 45,33% 80.00%
40,83% 70.00%
40 37,82% 60.00%
Persentase
34,31% 32,16% 32,7% 35,02
50.00% %(194)
30 27,94% 26,71% 40.00%
30.00%
20 20.00% 6,50%(36) 4,51%(25)
10.00%
10 0.00%
Jumlah Isolat Jumlah ESBL Jumlah PAN Jumlah
RESISTEN MRSA
0
Macam Isolat
40 40 WHO/
35 PPRA
30 26- ESBL
28 RSD 56%
20 RSD S
S
10 9 AMRI
0 N
2000 2005 2010 2013 2016
PEMICU RESISTENSI
SELECTIVE
PRESSURE
Hasil
Kategori Sby Semg
(%) (%)
Tidak ada
indikasi 76 53
terapi
Tidak ada
indikasi 55 81
profilaksis
• Blood stream
• Pneumonia
HAI AMR • UTI
• SSI
Food Kurikul
Knowled Residu AB Insent um
ge if
(+)
Training
R AB / R /Semina
OTC/Apat self AMR AB/ Knowle r
ek medikas dge
i RS DR Worksh
op
Regulasi
Mikro ASP KM/K
klinik FT
Farma TOP
si MGT
klinik
PPI Klinis
i
HEALTH RESOURCES IN INDONESIA 2016
CEGAH
SELECTIVE CEGAH KENDALI
ANTIBIOTIK KEWASPADAAN
DEKOLONISASI
BIJAK UNIVERSAL
40 40 40
35
30 30 ESBL
28 RSD
20 RSD S 20
S
10 9 AMRI
0 N
2000 2005 2010 2013 2016 2017 2018 2019
TERIMA KASIH